NCT06385145View on ClinicalTrials.gov

A Bioavailability Study of Two Different PEG-rhGH Preparations.

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 8, 2024

Primary Completion Date

July 5, 2024

Study Completion Date

March 26, 2025

Conditions
Pediatric Growth Hormone Deficiency (PGHD)
Interventions
DRUG

PEG-rhGH with new preparation (T)

A single subcutaneous injection of PEG-rhGH with new preparation

DRUG

PEG-rhGH with present preparation (R)

A single subcutaneous injection of PEG-rhGH with present preparation

Trial Locations (1)

610000

Chengdu Xinhua Hospital, Chengdu

All Listed Sponsors
lead

Changchun GeneScience Pharmaceutical Co., Ltd.

INDUSTRY

NCT06385145 - A Bioavailability Study of Two Different PEG-rhGH Preparations. | Biotech Hunter | Biotech Hunter